These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 12452378)
1. Expression of P-glycoprotein and C-MOAT in human hepatocellular carcinoma: detection by immunostaining. Richart J; Brunt EM; Di Bisceglie AM Dig Dis Sci; 2002 Nov; 47(11):2454-8. PubMed ID: 12452378 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of P-glycoprotein in adenomatous hyperplasia of human liver with cirrhosis. Nagasue N; Dhar DK; Makino Y; Yoshimura H; Nakamura T J Hepatol; 1995 Feb; 22(2):197-201. PubMed ID: 7540636 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of technetium-99m tetrofosmin liver imaging to detect hepatocellular carcinoma and related to expression of P-glycoprotein or multidrug resistance associated protein-a preliminary report. Ding HJ; Huang WT; Tsai CS; Chang CS; Kao A Nucl Med Biol; 2003 Jul; 30(5):471-5. PubMed ID: 12831984 [TBL] [Abstract][Full Text] [Related]
4. MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis. Grudé P; Conti F; Mennecier D; Louvel A; Houssin D; Weill B; Calmus Y Cancer Lett; 2002 Dec; 186(1):107-13. PubMed ID: 12183082 [TBL] [Abstract][Full Text] [Related]
5. Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation. Chou YY; Cheng AL; Hsu HC J Gastroenterol Hepatol; 1997 Aug; 12(8):569-75. PubMed ID: 9304508 [TBL] [Abstract][Full Text] [Related]
6. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases. Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450 [TBL] [Abstract][Full Text] [Related]
7. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of expression and cellular localization of the multidrug resistance gene product P-glycoprotein in primary liver carcinoma. Itsubo M; Ishikawa T; Toda G; Tanaka M Cancer; 1994 Jan; 73(2):298-303. PubMed ID: 7904895 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Tsuboyama T; Onishi H; Kim T; Akita H; Hori M; Tatsumi M; Nakamoto A; Nagano H; Matsuura N; Wakasa K; Tomoda K Radiology; 2010 Jun; 255(3):824-33. PubMed ID: 20501720 [TBL] [Abstract][Full Text] [Related]
10. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis. van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213 [TBL] [Abstract][Full Text] [Related]
11. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Nies AT; König J; Pfannschmidt M; Klar E; Hofmann WJ; Keppler D Int J Cancer; 2001 Nov; 94(4):492-9. PubMed ID: 11745434 [TBL] [Abstract][Full Text] [Related]
12. Liver cell dysplasia: reactivities for c-met protein, Rb protein, E-cadherin and transforming growth factor-beta 1 in comparison with hepatocellular carcinoma. Zhao M; Zimmermann A Histol Histopathol; 1998 Jul; 13(3):657-70. PubMed ID: 9690121 [TBL] [Abstract][Full Text] [Related]
13. Human haptocorrin in hepatocellular carcinoma. Boisson F; Fremont S; Migeon C; Nodari F; Droesch S; Gerard P; Parache RM; Nicolas JP Cancer Detect Prev; 1999; 23(2):89-96. PubMed ID: 10101589 [TBL] [Abstract][Full Text] [Related]
14. [The expression of integrin beta 1 in normal hepatic tissues, hepatic cirrhosis tissues and hepatocellular carcinoma]. Zhao G; Cui J; Qin Q; Li SS; Yin T; Chen LB; Wu HS; Wang CY Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):353-6. PubMed ID: 20510000 [TBL] [Abstract][Full Text] [Related]
15. Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions. Reis H; Bertram S; Pott L; Canbay A; Gallinat A; Baba HA Pathol Oncol Res; 2017 Jan; 23(1):33-39. PubMed ID: 27276915 [TBL] [Abstract][Full Text] [Related]
16. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma. Szczepański W Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407 [TBL] [Abstract][Full Text] [Related]
17. Woodchuck p-glycoprotein found in virus-induced hepatocellular carcinomas binds anticancer drugs. Dunn SE; Cullen JM Cancer Lett; 1996 Dec; 110(1-2):177-80. PubMed ID: 9018098 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease. Yusof YA; Yan KL; Hussain SN Anal Quant Cytol Histol; 2003 Dec; 25(6):332-8. PubMed ID: 14714299 [TBL] [Abstract][Full Text] [Related]
19. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line. Gu W; Fang FF; Li B; Cheng BB; Ling CQ Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of ganglioside components in hepatocellular carcinoma and liver cirrhosis using monoclonal antibody. Tanno M; Yamada H; Kyomasu Y; Inaniwa Y; Hano H; Myoga A Lab Invest; 1993 Apr; 68(4):456-64. PubMed ID: 7683070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]